middle.news
FDA Drops Black Box Warning, Mayne Pharma Poised for Growth in Menopause Therapies
11:51am on Wednesday 12th of November, 2025 AEDT
•
Pharmaceuticals
Read Story
FDA Drops Black Box Warning, Mayne Pharma Poised for Growth in Menopause Therapies
11:51am on Wednesday 12th of November, 2025 AEDT
Key Points
FDA removes black box warnings on menopause hormone therapies
Mayne Pharma’s BIJUVA and IMVEXXY to update product labels accordingly
Regulatory change expected to boost prescribing confidence and market expansion
FDA cites outdated risk perceptions as barrier to therapy adoption
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE